DOCSLIB.ORG

Sirt3) Regulates Skeletal Muscle Metabolism and Insulin Signaling Via Altered Mitochondrial Oxidation and Reactive Oxygen Species Production

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Sirt3) Regulates Skeletal Muscle Metabolism and Insulin Signaling Via Altered Mitochondrial Oxidation and Reactive Oxygen Species Production Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production Enxuan Jinga, Brice Emanuellia, Matthew D. Hirscheyb,c, Jeremie Bouchera, Kevin Y. Leea, David Lombardd,1, Eric M. Verdinb,c, and C. Ronald Kahna,2 aJoslin Diabetes Center, Harvard Medical School, Boston, MA 02215; bGladstone Institute of Virology and Immunology, San Francisco, CA 94158; cUniversity of California, San Francisco, CA 94143; and dDepartment of Genetics, Harvard Medical School, Boston, MA Contributed by C. Ronald Kahn, July 20, 2011 (sent for review April 14, 2011) Sirt3 is a member of the sirtuin family of protein deacetylases that early, or even primary, contributor to development of skeletal is localized in mitochondria and regulates mitochondrial function. muscle insulin resistance and type 2 diabetes. Sirt3 expression in skeletal muscle is decreased in models of type 1 In recent years, the sirtuin family of NAD+-dependent and type 2 diabetes and regulated by feeding, fasting, and caloric deacetylases has emerged as important regulators of metabolism. restriction. Sirt3 knockout mice exhibit decreased oxygen con- Among seven members of the sirtuin family, Sirt3 is of particular sumption and develop oxidative stress in skeletal muscle, leading interest with regard to mitochondrial function because it is lo- to JNK activation and impaired insulin signaling. This effect is mim- calized primarily in mitochondria (16). Sirt3 has been shown to Sirt3 icked by knockdown of in cultured myoblasts, which exhibit deacetylate and thereby regulate several mitochondrial targets, reduced mitochondrial oxidation, increased reactive oxygen spe- including acetyl-CoA synthase 2 and glutamate dehydrogenase cies, activation of JNK, increased serine and decreased tyrosine (17, 18). It has been suggested that Sirt3 is also closely involved in phosphorylation of IRS-1, and decreased insulin signaling. Thus, Sirt3 energy homeostasis and regulation of ATP production in various plays an important role in diabetes through regulation of Sirt3 mitochondrial oxidation, reactive oxygen species production, and tissues (19). Recently, we have shown that plays an im- insulin resistance in skeletal muscle. portant role in hepatic lipid metabolism (20). Through these and other effects, Sirt3 has been shown to be involved in mitochon- mitochondrial metabolism | protein acetylation drial function and is associated with aging (21, 22). We previously found that Sirt3 expression is significantly de- creased in muscle of mice with insulin-deficient diabetes (23), nsulin resistance in skeletal muscle is a major and early feature Iin the pathogenesis of type 2 diabetes (1, 2). This pathological suggesting that decreased Sirt3 activity could contribute to the condition has been shown to involve decreased activity of the in- metabolic abnormalities of diabetes. In the present study, we Sirt3 sulin signaling network with reduced tyrosine phosphorylation of demonstrate that skeletal muscle expression is altered in the insulin receptor and its substrates, decreased activation of models of both type 1 and type 2 diabetes and that alteration in phosphatidylinositol 3-kinase (PI 3-kinase), and decreased acti- Sirt3 expression regulates mitochondrial metabolism and pro- vation of Akt/PKB (protein kinase B), leading to reduced glucose duction of ROS, which in turn alters insulin signaling. These uptake and other metabolic abnormalities (3–5). Another early findings suggest a broad-reaching role of Sirt3 in altered muscle feature of type 2 diabetes is altered mitochondrial function in metabolism in both normal and diabetic states. muscle. Reduced expression of multiple nuclear-encoded genes involved in mitochondrial oxidative phosphorylation and alter- Results ations in mitochondrial morphology have been observed in skel- Changes in Sirt3 Expression in Models of Diabetes and Aging. etal muscle of both rodent models of diabetes and humans with Quantitative PCR using muscle from streptozotocin (STZ) di- type 2 diabetes (6–8). Impaired mitochondrial lipid oxidation and abetic mice revealed an w50% decrease of Sirt3 mRNA, similar glycolytic capacity have also been observed in individuals with to previous data from microarrays (23), and Western blot anal- diabetes and obesity, whereas enhanced mitochondrial lipid oxi- ysis confirmed a parallel decrease of Sirt3 protein (Fig. 1A). dation capacity has been associated with improved insulin re- Likewise, analysis of skeletal muscle from mice made obese by sistance (9, 10). This reduced expression and/or activity of a chronic high-fat diet revealed a >50% decrease of Sirt3 mRNA mitochondrial proteins has been closely associated with altered and protein compared with samples from mice fed a normal skeletal muscle physiology and metabolism. Some, but not all, chow diet (Fig. 1B). Conversely, caloric restriction of mice for 12 studies have found similar alterations in skeletal muscle of indi- wk resulted in a 2.5-fold increase of Sirt3 mRNA and protein in viduals with a family history positive for type 2 diabetes (8, 11). skeletal muscle (Fig. 1C). By contrast, there was no change in Reduced oxidative capacity and reduced ATP synthesis rates have muscle Sirt3 expression level with aging as demonstrated by a also been shown in individuals with type 2 diabetes and in some nondiabetic individuals with a family history for diabetes (12). comparison of 3- and 24-mo-old mice (Fig. S1). In addition to its role in substrate metabolism, the mito- chondrion is the major production site of reactive oxygen species (ROS). When ROS level is excessive or there is impaired ROS Author contributions: E.J., E.M.V., and C.R.K. designed research; E.J., B.E., M.D.H., J.B., and K.Y.L. performed research; D.L. contributed new reagents/analytic tools; E.J., B.E., and clearance, the oxidative stress response can activate serine/ M.D.H. analyzed data; and E.J. and C.R.K. wrote the paper. threonine kinases such as protein kinase C, S6 kinase, and Jun The authors declare no conflict of interest. N-terminal kinase (JNK), which can phosphorylate the insulin 1Present address: Department of Pathology and Institute of Gerontology, University of receptor (IR) and/or insulin receptor substrate (IRS) proteins Michigan, Ann Arbor, MI 48109. – (13 15), leading to a decrease in their tyrosine phosphorylation, 2To whom correspondence should be addressed. E-mail: [email protected]. decreased activation of PI 3-kinase and Akt, and resistance to edu. the metabolic actions of insulin. Collectively, these data suggest This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. that altered mitochondrial oxidative phosphorylation may be an 1073/pnas.1111308108/-/DCSupplemental. 14608e14613 | PNAS | August 30, 2011 | vol. 108 | no. 35 www.pnas.org/cgi/doi/10.1073/pnas.1111308108 Downloaded by guest on October 1, 2021 A B A B 1.2 1.6 25 3.0 1.4 WT 1.0 20 2.5 * 1.2 ) g 0.8 ( S3KO 2.0 1.0 s 15 * s 0.6 0.8 a 1.5 0.6 M 10 0.4 y 1.0 b 0.4 o 5 0.2 B 0.5 Sirt3 mRNA 0.2 0.0 0 0.0 0.0 Total Lean Total Fat Control STZ Diab Chow HFD Food intake/mouse/day(g) WT S3KO Sirt3 C D Tubulin 9500 1.0 9000 * 8500 * 0.9 C D 80002 4.0 2.5 7500 0.8 * * 7000 RER 2.0 * 6500 3.0 VO Mean 6000 0.7 1.5 5500 2.0 5000 0.6 1.0 WT S3KO WT S3KO WT S3KO WT S3KO 1.0 Light Cycle Dark Cycle Light Cycle Dark Cycle Sirt3 mRNA 0.5 0.0 0.0 Control CR Fed Fasted Refed E F 2.5 * WT S3KO Sirt3 2.0 Tubulin TBARS 1.5 p-JNK 1.0 Fig. 1. Sirt3 expression in different states of diabetes and aging. (A) Skel- JNK Muscle etal muscles from the hind limbs of STZ diabetic mice and controls (8-wk-old 0.5 C57BL/6) were collected. RNA and protein was extracted and analyzed by 0.0 either quantitative PCR or Western blotting. (B) Skeletal muscles from the WT S3KO hind limb of obese high fat diet (HFD) and control mice were collected and processed for quantitative PCR and Western blot analysis for Sirt3 expres- G _ WT_ S3KO H 350 Ins ++ ++ * sion. (C) Hind-limb skeletal muscle of CR mice along with controls was col- WT pY-IR lected and processed for quantitative PCR and Western blot analysis. (D) S3KO IR 250 Mice were either randomly fed or fasted for 24 h; half of the fasted animals p-IRS1 Y612 were then refed for 16 h. After each treatment, quadriceps muscles from 150 fed, fasted, and refed groups were collected and processed for detection of p-Akt Glucose (mg/dl) Sirt3 expression as above. Akt p-Erk 50 0306090120150 MEDICAL SCIENCES Erk Time (min) Changes in Sirt3 expression can also occur rapidly as illus- trated by the effects of fasting and refeeding. After 24 h of Fig. 2. Sirt3 knockout mice have increased oxidative stress and insulin re- fasting, Sirt3 mRNA and protein expression in quadriceps muscle sistance in skeletal muscle accompanied by decreased respiration. (A) A DXA were decreased by w50% and were reversed after refeeding for scan was performed using 16-wk-old male C57BL/6 WT and KO mice (n =4), 16 h (Fig. 1D). The other mitochondrial sirtuin, Sirt4, was also body composition was measured, and Student’s t test was performed for fi down-regulated in ob/ob mice. During fasting, however, STZ- signi cance. (B) CLAMS analysis was performed using 16-wk-old male C57BL/ 6 WT and KO mice. Daily food intake per mouse over 48 h of CLAMS study induced diabetes and caloric restriction had no effect on ex- was calculated and Student’s t test was performed for significance.
Load more

Recommended publications
  • Understanding the Potential Role of Sirtuin 2 on Aging: Consequences of SIRT2.3 Overexpression in Senescence
    International Journal of Molecular Sciences Article Understanding the Potential Role of Sirtuin 2 on Aging: Consequences of SIRT2.3 Overexpression in Senescence Noemi Sola-Sevilla 1, Ana Ricobaraza 2, Ruben Hernandez-Alcoceba 2 , Maria S. Aymerich 3,4, Rosa M. Tordera 1 and Elena Puerta 1,* 1 Pharmacology and Toxicology Department, Faculty of Pharmacy, University of Navarra, Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain; [email protected] (N.S.-S.); [email protected] (R.M.T.) 2 Gene Therapy Program CIMA, University of Navarra, Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain; [email protected] (A.R.); [email protected] (R.H.-A.) 3 Departamento de Bioquímica y Genética, Facultad de Ciencias, Universidad de Navarra, 31008 Pamplona, Spain; [email protected] 4 Neuroscience Program CIMA, University of Navarra, Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain * Correspondence: [email protected] Abstract: Sirtuin 2 (SIRT2) has been associated to aging and age-related pathologies. Specifically, an age-dependent accumulation of isoform 3 of SIRT2 in the CNS has been demonstrated; however, no study has addressed the behavioral or molecular consequences that this could have on aging. In the present study, we have designed an adeno-associated virus vector (AAV-CAG-Sirt2.3-eGFP) for the overexpression of SIRT2.3 in the hippocampus of 2 month-old SAMR1 and SAMP8 mice. Our Citation: Sola-Sevilla, N.; results show that the specific overexpression of this isoform does not induce significant behavioral or Ricobaraza, A.; Hernandez-Alcoceba, molecular effects at short or long term in the control strain. Only a tendency towards a worsening in R.; Aymerich, M.S.; Tordera, R.M.; the performance in acquisition phase of the Morris Water Maze was found in SAMP8 mice, together Puerta, E.
    [Show full text]
  • Pan-Histone Deacetylase Inhibitors Regulate Signaling Pathways
    Majumdar et al. BMC Genomics 2012, 13:709 http://www.biomedcentral.com/1471-2164/13/709 RESEARCH ARTICLE Open Access Pan-histone deacetylase inhibitors regulate signaling pathways involved in proliferative and pro-inflammatory mechanisms in H9c2 cells Gipsy Majumdar1, Piyatilake Adris1, Neha Bhargava1, Hao Chen2 and Rajendra Raghow1,2* Abstract Background: We have shown previously that pan-HDAC inhibitors (HDACIs) m-carboxycinnamic acid bis-hydroxamide (CBHA) and trichostatin A (TSA) attenuated cardiac hypertrophy in BALB/c mice by inducing hyper-acetylation of cardiac chromatin that was accompanied by suppression of pro-inflammatory gene networks. However, it was not feasible to determine the precise contribution of the myocytes- and non-myocytes to HDACI-induced gene expression in the intact heart. Therefore, the current study was undertaken with a primary goal of elucidating temporal changes in the transcriptomes of cardiac myocytes exposed to CBHA and TSA. Results: We incubated H9c2 cardiac myocytes in growth medium containing either of the two HDACIs for 6h and 24h and analyzed changes in gene expression using Illumina microarrays. H9c2 cells exposed to TSA for 6h and 24h led to differential expression of 468 and 231 genes, respectively. In contrast, cardiac myocytes incubated with CBHA for 6h and 24h elicited differential expression of 768 and 999 genes, respectively. We analyzed CBHA- and TSA-induced differentially expressed genes by Ingenuity Pathway (IPA), Kyoto Encyclopedia of Genes and Genomes (KEGG) and Core_TF programs and discovered that CBHA and TSA impinged on several common gene networks. Thus, both HDACIs induced a repertoire of signaling kinases (PTEN-PI3K-AKT and MAPK) and transcription factors (Myc, p53, NFkB and HNF4A) representing canonical TGFβ, TNF-α, IFNγ and IL-6 specific networks.
    [Show full text]
  • Flawed Phospholipid Formation Or Faulty Fatty Acid Oxidation: Determining the Cause of Mitochondrial Dysfunction in Hearts Lacking Acsl1
    FLAWED PHOSPHOLIPID FORMATION OR FAULTY FATTY ACID OXIDATION: DETERMINING THE CAUSE OF MITOCHONDRIAL DYSFUNCTION IN HEARTS LACKING ACSL1 Trisha J. Grevengoed A dissertation submitted to the faculty at the University of North Carolina at Chapel Hill in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Nutrition (Biochemistry) in the School of Public Health. Chapel Hill 2015 Approved by: Rosalind A. Coleman Stephen D. Hursting Liza Makowski Leslie V. Parise Steven H. Zeisel © 2015 Trisha J. Grevengoed ALL RIGHTS RESERVED ii ABSTRACT Trisha J. Grevengoed: Fatty acid activation in cardiac mitochondria: The role of ACSL1 in phospholipid formation and remodeling, substrate switching, and autophagic flux (Under the direction of Rosalind A. Coleman) Cardiovascular disease is the number one cause of death worldwide. In the heart, mitochondria provide up to 95% of energy, with most of this energy coming from metabolism of fatty acids (FA). FA must be converted to acyl-CoAs by acyl-CoA synthetases (ACS) before entry into pathways of β- oxidation or glycerolipid synthesis. ACSL1 contributes more than 90% of total cardiac ACSL activity, and mice with an inducible knockout of ACSL1 (Acsl1T-/-) have impaired cardiac FA oxidation. The effects of loss of ACSL1 on mitochondrial respiratory function, phospholipid formation, or autophagic flux have not yet been studied. Acsl1T-/- hearts contained 3-fold more mitochondria with abnormal structure and displayed lower respiratory function. Because ACSL1 exhibited a strong substrate preference for linoleate (18:2), we investigated the composition of mitochondrial phospholipids. Acsl1T-/- hearts contained 83% less tetralinoleoyl-cardiolipin (CL), the major form present in control hearts.
    [Show full text]
  • Assessment of Sirtuin 3 and Sirtuin 4 Level in Patients with Diabetes
    JCDP Sirtuins10.5005/jp-journals-10024-2405 in Diabetes and Periodontitis ORIGINAL RESEARCH Assessment of Sirtuin 3 and Sirtuin 4 Level in Patients with Diabetes Mellitus and Periodontitis: A Clinical Study 1Rashmi Laddha, 2Monica Mahajania, 3Amruta Khadse, 4Rajat Bajaj, 5Rashmi Jawade, 6Shashwati Choube ABSTRACT (6.37 ± 0.30). Mean fasting blood sugar (mg/dL) in group I was 80.40 ± 13.05, in group II, it was 160.40 ± 27.20, in group III, it Aim: Periodontitis is considered as infection in periodontal was 77.00 ± 12.78, and in group IV, it was 264.20 ± 53.17. The supporting structure leading to tooth mobility and ulcerated nonsignificant mean expression of SIRT 3 was seen in group I periodontal pockets. The present study was conducted to assess (29.20 ± 3.14), group II (29.19 ± 2.18), group III (28.89 ± 2.77), Sirtuin 3 (SIRT 3) and SIRT 4 level in patients with diabetes and group IV (29.59 ± 5.82). In group I, the mean level of SIRT mellitus (DM) and periodontitis. 4 was 28.93 ± 12.55, in group II, it was 28.82 ± 9.14, in group Materials and methods: The present study was conducted on III, it was 28.88 ± 6.03, and in group IV, it was 29.05 ± 10.68. 60 subjects. Subjects were divided into four groups, groups I to Conclusion: Association of DM and periodontitis is well known. IV. Each group comprised of 15 subjects. In all subjects, fasting The SIRT 3 and SIRT 4 are useful indicators of glycemic level blood glucose level was assessed.
    [Show full text]
  • Nicotinamide Mononucleotide Requires SIRT3 to Improve Cardiac Function and Bioenergetics in a Friedreich’S Ataxia Cardiomyopathy Model
    RESEARCH ARTICLE Nicotinamide mononucleotide requires SIRT3 to improve cardiac function and bioenergetics in a Friedreich’s ataxia cardiomyopathy model Angelical S. Martin,1,2 Dennis M. Abraham,3 Kathleen A. Hershberger,1,2 Dhaval P. Bhatt,1 Lan Mao,3 Huaxia Cui,1 Juan Liu,2 Xiaojing Liu,2 Michael J. Muehlbauer,1 Paul A. Grimsrud,1 Jason W. Locasale,1,2 R. Mark Payne,4 and Matthew D. Hirschey1,2,5 1Duke Molecular Physiology Institute and Sarah W. Stedman Nutrition and Metabolism Center, 2Department of Pharmacology and Cancer Biology, 3Department of Medicine, Division of Cardiology and Duke Cardiovascular Physiology Core, Duke University Medical Center, Durham, North Carolina, USA. 4Department of Medicine, Division of Pediatrics, Indiana University, Indianapolis, Indiana, USA. 5Department of Medicine, Division of Endocrinology, Metabolism, & Nutrition, Duke University Medical Center, Durham, North Carolina, USA. Increasing NAD+ levels by supplementing with the precursor nicotinamide mononucleotide (NMN) improves cardiac function in multiple mouse models of disease. While NMN influences several aspects of mitochondrial metabolism, the molecular mechanisms by which increased NAD+ enhances cardiac function are poorly understood. A putative mechanism of NAD+ therapeutic action exists via activation of the mitochondrial NAD+-dependent protein deacetylase sirtuin 3 (SIRT3). We assessed the therapeutic efficacy of NMN and the role of SIRT3 in the Friedreich’s ataxia cardiomyopathy mouse model (FXN-KO). At baseline, the FXN-KO heart has mitochondrial protein hyperacetylation, reduced Sirt3 mRNA expression, and evidence of increased NAD+ salvage. Remarkably, NMN administered to FXN-KO mice restores cardiac function to near-normal levels. To determine whether SIRT3 is required for NMN therapeutic efficacy, we generated SIRT3-KO and SIRT3-KO/FXN-KO (double KO [dKO]) models.
    [Show full text]
  • Sirt3 Exerts Its Tumor-Suppressive Role by Increasing P53 and Attenuating Response to Estrogen in MCF-7 Cells
    antioxidants Article Sirt3 Exerts Its Tumor-Suppressive Role by Increasing p53 and Attenuating Response to Estrogen in MCF-7 Cells 1, 1, 1 2 Marija Pinteri´c y, Iva I. Podgorski y , Marijana Popovi´cHadžija , Vedrana Fili´c , Mladen Paradžik 2,3 , Bastien Lucien Jean Proust 1, Ana Dekani´c 1 , Ivan Ciganek 1, Denis Pleše 1, Dora Marˇcinko 1, Tihomir Balog 1 and Sandra Soboˇcanec 1,* 1 Division of Molecular Medicine, Ruđer Boškovi´cInstitute, 10000 Zagreb, Croatia; [email protected] (M.P.); [email protected] (I.I.P.); [email protected] (M.P.H.); [email protected] (B.L.J.P.); [email protected] (A.D.); [email protected] (I.C.); [email protected] (D.P.); [email protected] (D.M.); [email protected] (T.B.) 2 Division of Molecular Biology, Ruđer Boškovi´cInstitute, 10000 Zagreb, Croatia; [email protected] (V.F.); [email protected] (M.P.) 3 Department Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre (MBC), University of Torino, 10124 Torino, Italy * Correspondence: [email protected]; Tel.: +385-1-4561-172 These authors contributed equally to this work. y Received: 25 February 2020; Accepted: 30 March 2020; Published: 1 April 2020 Abstract: Estrogen (E2) is a major risk factor for the initiation and progression of malignancy in estrogen receptor (ER) positive breast cancers, whereas sirtuin 3 (Sirt3), a major mitochondrial NAD+-dependent deacetylase, has the inhibitory effect on the tumorigenic properties of ER positive MCF-7 breast cancer cells. Since it is unclear if this effect is mediated through the estrogen receptor alpha (ERα) signaling pathway, in this study, we aimed to determine if the tumor-suppressive function of Sirt3 in MCF-7 cells interferes with their response to E2.
    [Show full text]
  • Inhibition of Mitochondrial Calcium Overload by SIRT3 Prevents Obesity Or Age
    Page 1 of 63 Diabetes Inhibition of mitochondrial calcium overload by SIRT3 prevents obesity or age- related whitening of brown adipose tissue Peng Gao1,#, Yanli Jiang1,2,#, Hao Wu1, Fang Sun1, Yaohong Li2, Hongbo He1, Bin Wang1, Zongshi Lu1, Yingru Hu1, Xiao Wei1, Yuanting Cui1, Chengkang He1, Lijuan Wang1, Hongting Zheng3, Gangyi Yang4, Daoyan Liu1, Zhencheng Yan1,*, Zhiming Zhu1,* 1Department of Hypertension and Endocrinology, Center for Hypertension and Metabolic Diseases, Daping Hospital, Third Military Medical University, Chongqing Institute of Hypertension, Chongqing 400042, China 2Department of Endocrinology, Menghai County People's Hospital, Xishuangbanna, Yunnan 666200, China. 3Department of Endocrinology, Translational Research Key Laboratory for Diabetes, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China 4Department of Endocrinology, The Second Affiliated Hospital, Chongqing Medical University and Chongqing Clinical Research Center for Geriatrics, Chongqing 400010, China #These authors contributed equally to this work *Correspondence to Zhencheng Yan, MD, PhD and Zhiming Zhu, MD, PhD, Department of Hypertension and Endocrinology, Center for Hypertension and Metabolic Diseases, Daping Hospital, Third Military Medical University, Chongqing Institute of Hypertension, 10 Chang Jiang Zhi Lu, Yuzhong District, Chongqing Diabetes Publish Ahead of Print, published online November 11, 2019 Diabetes Page 2 of 63 400042, China. Tel. +86-23-6876-7849. Email address: [email protected] (Z.Y.); [email protected] (Z.Z.). Word Count: 5207 Running title: Capsaicin inhibits BAT whitening by activating AMPK/SIRT3 pathway Key words: capsaicin, SIRT3, AMPK, brown adipose tissue, mitochondrial calcium overload Abstract The whitening and loss of brown adipose tissue (BAT) during obesity and aging promote metabolic disorders and related diseases. The imbalance of Ca2+ homeostasis accounts for the dysfunction and clearance of mitochondria during BAT whitening.
    [Show full text]
  • Theranostics NAD+-Boosting Therapy Alleviates Nonalcoholic Fatty Liver
    Theranostics 2021, Vol. 11, Issue 9 4381 Ivyspring International Publisher Theranostics 2021; 11(9): 4381-4402. doi: 10.7150/thno.53652 Research Paper NAD+-boosting therapy alleviates nonalcoholic fatty liver disease via stimulating a novel exerkine Fndc5/irisin Dong-Jie Li1,2,3*, Si-Jia Sun2,3*, Jiang-Tao Fu1*, Shen-Xi Ouyang2,3*, Qin-Jie Zhao,4 Li Su,5 Qing-Xi Ji,2,3 Di-Ynag Sun1, Jia-Hui Zhu2,3, Guo-Yan Zhang2,3, Jia-Wei Ma2,3, Xiu-Ting Lan,2,3 Yi Zhao,2,3 Jie Tong2,3, Guo-Qiang Li,1,6 Fu-Ming Shen2,3, Pei Wang1,2,3 1. Department of Pharmacology, School of Pharmacy, Second Military Medical University/Naval Medical University, Shanghai, China. 2. Department of Pharmacy, School of Medicine, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China. 3. Tongji University School of Medicine, Shanghai, China. 4. Department of Organic Chemistry, School of Pharmacy, Second Military Medical University/Naval Medical University, Shanghai, China. 5. Institute of Translational Medicine, Shanghai University, Shanghai, China. 6. School of Life Science, East China Normal University, Shanghai, China. *These authors contributed equally to this work. Corresponding author: Prof. Pei Wang, Ph.D, MD, Department of Pharmacology, School of Pharmacy, Second Military Medical University/Naval Medical University, Shanghai, China. Tel: 86-21-81871276; E-mail: [email protected]. © The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
    [Show full text]
  • Pyrroloquinoline Quinone Increases the Expression and Activity of Sirt1
    NUTRITION RESEARCH 35 (2015) 844– 849 Available online at www.sciencedirect.com ScienceDirect www.nrjournal.com Communication Pyrroloquinoline quinone increases the expression ☆ and activity of Sirt1 and -3 genes in HepG2 cells Jian Zhang a, Sunitha Meruvu a, Yudhishtar Singh Bedi a, Jason Chau a, Andrix Arguelles a, Robert Rucker b, Mahua Choudhury a,⁎ a Department of Pharmaceutical Sciences, Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Kingsville, TX, USA b Department of Nutrition, University of California, Davis, CA, USA ARTICLE INFO ABSTRACT Article history: Sirtuin (Sirt) 1 and Sirt 3 are nicotinamide adenine dinucleotide (+)-dependent protein Received 24 March 2015 deacetylases that are important to a number of mitochondrial-related functions; thus, Revised 24 June 2015 identification of sirtuin activators is important. Herein, we hypothesize that pyrroloquinoline Accepted 30 June 2015 quinone (PQQ) can act as a Sirt1/Sirt3 activator. In HepG2 cell cultures, PQQ increased the expression of Sirt1 and Sirt3 gene, protein, and activity levels (P < .05). We also observed a Keywords: significant increase in nicotinamide phosphoribosyltransferase gene expression (as early as 18 Sirtuins hours) and increased NAD+ activity at 24 hours. In addition, targets of Sirt1 and Sirt3 Pyrroloquinoline quinone (peroxisome proliferator–activated receptor γ coactivator 1α, nuclear respiratory factor 1 and 2, Metabolic syndrome and mitochondrial transcription factor A) were increased at 48 hours. This is the first report Mitochondria that demonstrates PQQ as an activator of Sirt1 and Sirt3 expression and activity, making it an Aging attractive therapeutic agent for the treatment of metabolic diseases and for healthy aging. Mitochondrial biogenesis regulators Based on our study and the available data in vivo, PQQ has the potential to serve as a therapeutic nutraceutical, when enhancing mitochondrial function.
    [Show full text]
  • Sirtuin 3–Dependent Mitochondrial Dynamic Improvements Protect Against Acute Kidney Injury
    Sirtuin 3–dependent mitochondrial dynamic improvements protect against acute kidney injury Marina Morigi, … , Giuseppe Remuzzi, Ariela Benigni J Clin Invest. 2015;125(2):715-726. https://doi.org/10.1172/JCI77632. Research Article Nephrology Acute kidney injury (AKI) is a public health concern with an annual mortality rate that exceeds those of breast and prostate cancer, heart failure, and diabetes combined. Oxidative stress and mitochondrial damage are drivers of AKI- associated pathology; however, the pathways that mediate these events are poorly defined. Here, using a murine cisplatin-induced AKI model, we determined that both oxidative stress and mitochondrial damage are associated with reduced levels of renal sirtuin 3 (SIRT3). Treatment with the AMPK agonist AICAR or the antioxidant agent acetyl-l- carnitine (ALCAR) restored SIRT3 expression and activity, improved renal function, and decreased tubular injury in WT animals, but had no effect in Sirt3–/– mice. Moreover, Sirt3-deficient mice given cisplatin experienced more severe AKI than WT animals and died, and neither AICAR nor ALCAR treatment prevented death in Sirt3–/– AKI mice. In cultured human tubular cells, cisplatin reduced SIRT3, resulting in mitochondrial fragmentation, while restoration of SIRT3 with AICAR and ALCAR improved cisplatin-induced mitochondrial dysfunction. Together, our results indicate that SIRT3 is protective against AKI and suggest that enhancing SIRT3 to improve mitochondrial dynamics has potential as a strategy for improving outcomes of renal injury. Find the latest version: https://jci.me/77632/pdf The Journal of Clinical Investigation RESEARCH ARTICLE Sirtuin 3–dependent mitochondrial dynamic improvements protect against acute kidney injury Marina Morigi,1 Luca Perico,1 Cinzia Rota,1 Lorena Longaretti,1 Sara Conti,1 Daniela Rottoli,1 Rubina Novelli,1 Giuseppe Remuzzi,1,2 and Ariela Benigni1 1IRCCS — Istituto di Ricerche Farmacologiche “Mario Negri,” Centro Anna Maria Astori, Science & Technology Park Kilometro Rosso, Bergamo, Italy.
    [Show full text]
  • Implications of Mitochondrial Unfolded Protein Response and Mitokines: a Perspective on Fatty Liver Diseases
    Review Endocrinol Metab 2019;34:39-46 https://doi.org/10.3803/EnM.2019.34.1.39 Article pISSN 2093-596X · eISSN 2093-5978 Implications of Mitochondrial Unfolded Protein Response and Mitokines: A Perspective on Fatty Liver Diseases Hyon-Seung Yi Research Center for Endocrine and Metabolic Diseases, Chungnam National University College of Medicine, Daejeon, Korea The signaling network of the mitochondrial unfolded protein response (UPRmt) and mitohormesis is a retrograde signaling pathway through which mitochondria-to-nucleus communication occurs in organisms. Recently, it has been shown that the UPRmt is closely associated with metabolic disorders and conditions involving insulin resistance, such as alcoholic and non-alcoholic fatty liver and fibrotic liver disease. Scientific efforts to understand the UPRmt and mitohormesis, as well as to establish the mitochondrial pro- teome, have established the importance of mitochondrial quality control in the development and progression of metabolic liver dis- eases, including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). In this review, we integrate and discuss the recent data from the literature on the UPRmt and mitohormesis in metabolic liver diseases, including NAFLD/NASH and fibrosis. Keywords: Mitochondria; Fatty liver; Metabolism; Obesity; Insulin resistance INTRODUCTION have abundant mitochondria [2]. This means that mitochondrial dysfunction in hepatocytes results in cellular damage, which is Metabolic liver diseases constitute a major health burden. linked to fatty liver diseases. For instance, chronic alcohol con- Among them, fatty liver, characterized by the presence of large sumption alters mitochondrial oxidative phosphorylation in the lipid vacuoles within the cytosol in hepatocytes, is a benign liver by suppressing the synthesis of respiratory complex pro- condition, but pathognomonic for non-alcoholic fatty liver dis- teins [3], and hepatic mitochondria are structurally and func- ease (NAFLD) and alcoholic liver injury.
    [Show full text]
  • PGC-1Α, Sirtuins and Parps in Huntington's Disease and Other
    Neurochemical Research (2019) 44:2423–2434 https://doi.org/10.1007/s11064-019-02809-1 ORIGINAL PAPER PGC‑1α, Sirtuins and PARPs in Huntington’s Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All Alejandro Lloret1,2 · M. Flint Beal1 Received: 28 January 2019 / Revised: 2 May 2019 / Accepted: 2 May 2019 / Published online: 7 May 2019 © Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract In this review, we summarize the available published information on the neuroprotective efects of increasing nicotinamide adenine dinucleotide (NAD+) levels in Huntington’s disease models. We discuss the rationale of potential therapeutic beneft of administering nicotinamide riboside (NR), a safe and efective NAD+ precursor. We discuss the agonistic efect on the Sirtuin1-PGC-1α-PPAR pathway as well as Sirtuin 3, which converge in improving mitochondrial function, decreasing ROS production and ameliorating bioenergetics defcits. Also, we discuss the potential synergistic efect of increasing NAD+ combined with PARPs inhibitors, as a clinical therapeutic option not only in HD, but other neurodegenerative conditions. Keywords Huntington’s disease · NAD+ · Nicotinamide Riboside · Sirtruins · PGC-1 alpha · PARPs Introduction [1]. HD is characterized by striatal degeneration, behavio- ral and cognitive impairments, and involuntary choreiform Mitochondrial dysfunction and ROS production are a com- movements. The toxic efects of mHtt include transcriptional mon pathogenic features present among many neurodegen- dysregulation, oxidative damage, excitotoxicity and bioener- erative conditions, such as Alzheimer’s, Parkinson’s and getic defects [2–4]. One element in which all these pathways Huntington’s disease (HD). HD is an autosomal-dominant seem to converge is PGC-1α, whose activation is modulated, neurodegenerative disorder that is considered as the fag- among others, by the NAD+ dependent deacetylase Sirtuin ship for studying the pathogenic pathways involved in neural 1 (SIRT1).
    [Show full text]